Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.

Brennan L, Devlin KM, Xie SX, Mechanic-Hamilton D, Tran B, Hurtig HH, Chen-Plotkin A, Chahine LM, Morley JF, Duda JE, Roalf DR, Dahodwala N, Rick J, Trojanowski JQ, Moberg PJ, Weintraub D.

J Parkinsons Dis. 2017;7(2):385-395. doi: 10.3233/JPD-171081.

PMID:
28387684
2.

Determinants of Dyadic Relationship and Its Psychosocial Impact in Patients with Parkinson's Disease and Their Spouses.

Karlstedt M, Fereshtehnejad SM, Aarsland D, Lökk J.

Parkinsons Dis. 2017;2017:4697052. doi: 10.1155/2017/4697052. Epub 2017 Feb 14.

3.

Spanish version of the Parkinson's Disease Questionnaire-Carer (PDQ-Carer).

Ferrer-Cascales R, Cabañero-Martínez MJ, Sánchez-SanSegundo M, Congost-Maestre N, Jenkinson C.

Health Qual Life Outcomes. 2016 Nov 4;14(1):154.

4.

Goal Setting for Cognitive Rehabilitation in Mild to Moderate Parkinson's Disease Dementia and Dementia with Lewy Bodies.

Watermeyer TJ, Hindle JV, Roberts J, Lawrence CL, Martyr A, Lloyd-Williams H, Brand A, Gutting P, Hoare Z, Edwards RT, Clare L.

Parkinsons Dis. 2016;2016:8285041. doi: 10.1155/2016/8285041. Epub 2016 Jun 29.

5.

Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire.

Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D.

Mov Disord. 2016 Jan;31(1):126-34. doi: 10.1002/mds.26339. Epub 2015 Aug 7.

6.

Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.

Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT.

Brain. 2015 Oct;138(Pt 10):2974-86. doi: 10.1093/brain/awv211. Epub 2015 Jul 14.

7.

Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson's Disease Dementia.

Oh YS, Kim JS, Lee PH.

J Mov Disord. 2015 May;8(2):98-102. doi: 10.14802/jmd.15041. Epub 2015 May 31.

8.

Abnormal metabolic pattern associated with cognitive impairment in Parkinson's disease: a validation study.

Meles SK, Tang CC, Teune LK, Dierckx RA, Dhawan V, Mattis PJ, Leenders KL, Eidelberg D.

J Cereb Blood Flow Metab. 2015 Sep;35(9):1478-84. doi: 10.1038/jcbfm.2015.112. Epub 2015 Jun 10.

9.

Neuropsychiatric co-morbidities in non-demented Parkinson's disease.

Rai NK, Goyal V, Kumar N, Shukla G, Srivastava AK, Singh S, Behari M.

Ann Indian Acad Neurol. 2015 Jan-Mar;18(1):33-8. doi: 10.4103/0972-2327.144287.

10.

Neuropsychiatric symptoms in Parkinson's disease dementia are associated with increased caregiver burden.

Oh YS, Lee JE, Lee PH, Kim JS.

J Mov Disord. 2015 Jan;8(1):26-32. doi: 10.14802/jmd.14019. Epub 2015 Jan 13.

11.

Virtual multiple errands test (VMET): a virtual reality-based tool to detect early executive functions deficit in Parkinson's disease.

Cipresso P, Albani G, Serino S, Pedroli E, Pallavicini F, Mauro A, Riva G.

Front Behav Neurosci. 2014 Dec 5;8:405. doi: 10.3389/fnbeh.2014.00405. eCollection 2014.

12.

Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.

van Steenoven I, Aarsland D, Hurtig H, Chen-Plotkin A, Duda JE, Rick J, Chahine LM, Dahodwala N, Trojanowski JQ, Roalf DR, Moberg PJ, Weintraub D.

Mov Disord. 2014 Dec;29(14):1809-15. doi: 10.1002/mds.26062. Epub 2014 Nov 7.

13.

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.

Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz B, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, Revilla FJ, Devoto J, Hu SC, Cholerton BA, Wan JY, Montine TJ, Edwards KL, Zabetian CP.

JAMA Neurol. 2014 Nov;71(11):1405-12. doi: 10.1001/jamaneurol.2014.1455.

14.

Screening for impaired cognitive domains in a large Parkinson's disease population and its application to the diagnostic procedure for Parkinson's disease dementia.

Ohta K, Takahashi K, Gotoh J, Yamaguchi K, Seki M, Nihei Y, Iwasawa S, Suzuki N; Keio Parkinson's Disease Database.

Dement Geriatr Cogn Dis Extra. 2014 May 23;4(2):147-59. doi: 10.1159/000362124. eCollection 2014 May.

15.

Correlation of sleep disturbance and cognitive impairment in patients with Parkinson's disease.

Kim EJ, Baek JH, Shin DJ, Park HM, Lee YB, Park KH, Shin DH, Noh Y, Sung YH.

J Mov Disord. 2014 Apr;7(1):13-8. doi: 10.14802/jmd.14003. Epub 2014 Apr 30.

16.

Consultation-liaison Approach for the Management of Psychiatric Manifestations in Parkinson's Disease and Related Disorders: A Report from Neuropsychiatric Hospital, India.

Thippeswamy H, Viswanath B, Babu GN, Reddi VS, Chaturvedi SK.

Indian J Psychol Med. 2014 Apr;36(2):134-7. doi: 10.4103/0253-7176.130971.

17.

Systematic review of the effectiveness of occupational therapy-related interventions for people with Parkinson's disease.

Foster ER, Bedekar M, Tickle-Degnen L.

Am J Occup Ther. 2014 Jan-Feb;68(1):39-49. doi: 10.5014/ajot.2014.008706. Review.

18.

Mild cognitive impairment in Parkinson's disease: a review of current concepts.

Palavra NC, Naismith SL, Lewis SJ.

Neurol Res Int. 2013;2013:576091. doi: 10.1155/2013/576091. Epub 2013 Jul 1.

19.

Carer quality of life and experiences of health services: a cross-sectional survey across three neurological conditions.

Peters M, Jenkinson C, Doll H, Playford ED, Fitzpatrick R.

Health Qual Life Outcomes. 2013 Jun 25;11:103. doi: 10.1186/1477-7525-11-103.

20.

Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.

Christopher L, Strafella AP.

J Neuropsychol. 2013 Sep;7(2):225-40. doi: 10.1111/jnp.12015. Epub 2013 Apr 1. Review.

Supplemental Content

Support Center